The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
The bromodomain: a conserved sequence found in human,Drosophila and yeast proteins
Open accessAbstract
Identification of conserved domains or motifs in proteins may aid in the localization and analysis of important structural and functional regions. We report here a protein sequence motif, called the bromodomain (1), that has been found in six genes from humans (CCG1 and RING3), Drosophila (fsh and brm), and yeast (SPT7 and SNF2). The fsh and brm genes are required maternally for proper expression of certain homeotic genes (1,2). The SPT7 and SNF2 genes of Saccharomyces cerevisiae encode transcriptional activators (3,4). The SNF2 and brm proteins have extensive sequence homology (1). It is not clear whether the two human genes are involved in processes. CCG1 is a DNA-binding protein that complements temperature sensitive mutations that cause cell cycle arrest in Gl (5). The RING3 gene is a newly identified human gene of unknown function, mapping to the class II region of the human major histocompatibility locus, that has substantial homology to the fsh gene (6). Each of these proteins has one or two copies of the 61 —63 amino acid bromodomain (Figure 1). The sequence identity is highest (~ 80%) between the corresponding fsh and RING3 repeats. More typically, any two motifs show 25-40% identity, with 50-60% identity between two repeats within the same protein. There are seven invariant residues, four of which are aromatic amino acids, and numerous conservative substitutions. The location of the motif(s) within the individual proteins is variable, and two motifs may be present in tandem or separated by sequences unrelated to the motif. Secondary structure prediction methods were applied to the bromodomain and revealed two strongly predicted amphipathic a helices followed by reverse turns. Four of the invariant residues are located within the turns, and the other three are located among four highly conserved proline residues at the N terminus. The functional significance of the bromodomain is unknown, and experiments with the two yeast proteins indicate that it may be dispensable in some cases (6; P.Tan and F.W., unpublished data). However, the widespread conservation of the bromodomain suggests that it is important for some aspects of protein function. We speculate that the hydrophobic surfaces of the helices and the invariant hydrophobic residues could serve as sites of intramolecular or intermolecular protein-protein interaction. Such interactions could influence the assembly or activity of multicomponent complexes involved in transcription activation or other cellular processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tamkun, J. W., Deuring, R., Scott, M. P., Kissinger, M., Pattatucci, A. M., Kaufman, T. C., & Kennison, J. A. (1992) · Cell · doi:10.1016/0092-8674(92)90191-e · Cited by 971
Prediction of immunodominant helper T cell antigenic sites from the primary sequence.
Margalit, H., Spouge, J. L., Cornette, J. L., Cease, K. B., Delisi, C., & Berzofsky, J. A. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.7.2213 · Cited by 474
Functional interdependence of the yeast SNF2, SNF5, and SNF6 proteins in transcriptional activation.
Laurent, B. C., Treitel, M. A., & Carlson, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2687 · Cited by 240
Sekiguchi, T., Nohiro, Y., Nakamura, Y., Hisamoto, N., & Nishimoto, T. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.6.3317-3325.1991 · Cited by 126
Three Genes Are Required for trans-Activation of Ty Transcription in Yeast
Winston, F., Dollard, C. A., Malone, E. A., Clare, J. J., Kapakos, J. G., Farabaugh, P. J., & Minehart, P. L. (1987) · Genetics · doi:10.1093/genetics/115.4.649 · Cited by 93
Self-citationBeck, S., Hanson, I. M., Kelly, A. P., Pappin, D., & Trowsdale, J. (1992) · DNA sequence · doi:10.3109/10425179209020804 · Cited by 86
Self-citationThe Drosophila fsh locus, a maternal effect homeotic gene, encodes apparent membrane proteins
Haynes, S. R., Mozer, B. A., Bhatia‐Dey, N., & Dawid, I. B. (1989) · Developmental Biology · doi:10.1016/0012-1606(89)90094-8 · Cited by 82
Self-citation
Cited by
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,134
Acetylation of Histones and Transcription-Related Factors
Sterner, D. E., & Berger, S. L. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.2.435-459.2000 · Cited by 1,780
Structure and ligand of a histone acetyltransferase bromodomain
Dhalluin, C., Carlson, J. E., Zeng, L., He, C., Aggarwal, A. K., Zhou, M.-M., & Zhou, M.-M. (1999) · Nature · doi:10.1038/20974 · Cited by 1,732
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Filippakopoulos, P., Picaud, S., Mangos, M., Keates, T., Lambert, J.-P., Barsyte-Lovejoy, D., Felletar, I., Volkmer, R., Müller, S., Pawson, T., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.013 · Cited by 1,694
Brownell, J. E., Zhou, J., Ranalli, T., Kobayashi, R., Edmondson, D. G., Roth, S. Y., & Allis, C. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81063-6 · Cited by 1,640
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Yang, X.-J., Ogryzko, V. V., Nishikawa, J.-I., Howard, B. H., & Nakatani, Y. (1996) · Nature · doi:10.1038/382319a0 · Cited by 1,479
Epigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327
Eckner, R., Ewen, M. E., Newsome, D., Gerdes, M., DeCaprio, J. A., Lawrence, J. B., & Livingston, D. M. (1994) · Genes & Development · doi:10.1101/gad.8.8.869 · Cited by 1,045
The PHD finger: Implications for chromatin-mediated transcriptional regulation
Aasland, R. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)88957-4 · Cited by 853
Structure and Function of a Human TAF II 250 Double Bromodomain Module
Jacobson, R. H., Ladurner, A. G., King, D. S., & Tjian, R. (2000) · Science · doi:10.1126/science.288.5470.1422 · Cited by 843
Targeting oncogenic Myc as a strategy for cancer treatment
Chen, H., Liu, H., & Qing, G. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0008-7 · Cited by 806
Bromodomain: an acetyl‐lysine binding domain
Zeng, L., & Zhou, M.-M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(01)03309-9 · Cited by 746
Statistics of local complexity in amino acid sequences and sequence databases
Wootton, J. C., & Federhen, S. (1993) · Computers & Chemistry · doi:10.1016/0097-8485(93)85006-x · Cited by 729
The TAFII250 Subunit of TFIID Has Histone Acetyltransferase Activity
Mizzen, C. A., Yang, X.-J., Kokubo, T., Brownell, J. E., Bannister, A. J., Owen-Hughes, T., Workman, J., Wang, L., Berger, S. L., Kouzarides, T., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81821-8 · Cited by 727
Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions
Eisen, J. A., Sweder, K. S., & Hanawalt, P. C. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.14.2715 · Cited by 717
BET domain co-regulators in obesity, inflammation and cancer
Belkina, A. C., & Denis, G. V. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3256 · Cited by 711
KAP-1, a novel corepressor for the highly conserved KRAB repression domain.
Friedman, J. R., Fredericks, W. J., Jensen, D. E., Speicher, D. W., Huang, X. P., Neilson, E. G., & Rauscher, F. J. (1996) · Genes & Development · doi:10.1101/gad.10.16.2067 · Cited by 681
Khavari, P. A., Peterson, C. L., Tamkun, J. W., Mendel, D. B., & Crabtree, G. R. (1993) · Nature · doi:10.1038/366170a0 · Cited by 669
The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis
Dey, A., Chitsaz, F., Abbasi, A., Misteli, T., & Ozato, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1433065100 · Cited by 669
Le Douarin, B., Zechel, C., Garnier, J. M., Lutz, Y., Tora, L., Pierrat, P., Heery, D., Gronemeyer, H., Chambon, P., & Losson, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07194.x · Cited by 619
Gibbons, R. J., Picketts, D. J., Villard, L., & Higgs, D. R. (1995) · Cell · doi:10.1016/0092-8674(95)90287-2 · Cited by 633
Muchardt, C., & Yaniv, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06112.x · Cited by 591
Functions of bromodomain-containing proteins and their roles in homeostasis and cancer
Fujisawa, T., & Filippakopoulos, P. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.143 · Cited by 573
Le Douarin, B., Nielsen, A. L., Garnier, J. M., Ichinose, H., Jeanmougin, F., Losson, R., & Chambon, P. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01060.x · Cited by 544
Owen, D. J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.22.6141 · Cited by 542
Brownell, J. E., & Allis, C. D. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)80048-7 · Cited by 534
Hassan, A. H., Prochasson, P., Neely, K. E., Galasinski, S. C., Chandy, M., Carrozza, M. J., & Workman, J. L. (2002) · Cell · doi:10.1016/s0092-8674(02)01005-x · Cited by 532
The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases
Yang, X.-J. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh252 · Cited by 515
E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators
Arany, Z. (1994) · Cell · doi:10.1016/0092-8674(94)90127-9 · Cited by 444
Bromodomains as therapeutic targets
Muller, S., Filippakopoulos, P., & Knapp, S. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001992 · Cited by 442
Correlated sequence-signatures as markers of protein-protein interaction
Sprinzak, E., & Margalit, H. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4920 · Cited by 400
Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics
Ali, I., Conrad, R. J., Verdin, E., & Ott, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00181 · Cited by 366
Sterner, D. E., Grant, P. A., Roberts, S. M., Duggan, L. J., Belotserkovskaya, R., Pacella, L. A., Winston, F., Workman, J. L., & Berger, S. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.86 · Cited by 364
Self-citationLysine acetylation and the bromodomain: a new partnership for signaling
Yang, X. (2004) · BioEssays · doi:10.1002/bies.20104 · Cited by 357
Taniguchi, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111849 · Cited by 336
Ito, T., Levenstein, M. E., Fyodorov, D. V., Kutach, A. K., Kobayashi, R., & Kadonaga, J. T. (1999) · Genes & Development · doi:10.1101/gad.13.12.1529 · Cited by 332
Structural Mechanism of the Bromodomain of the Coactivator CBP in p53 Transcriptional Activation
Mujtaba, S., He, Y., Zeng, L., Yan, S., Plotnikova, O., Sachchidanand, Sanchez, R., Zeleznik-Le, N. J., Ronai, Z., & Zhou, M.-M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(03)00528-8 · Cited by 319
Sobulo, O. M., Borrow, J., Tomek, R., Reshmi, S., Harden, A., Schlegelberger, B., Housman, D., Doggett, N. A., Rowley, J. D., & Zeleznik-Le, N. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8732 · Cited by 319
Houzelstein, D., Bullock, S. L., Lynch, D. E., Grigorieva, E. F., Wilson, V. A., & Beddington, R. S. P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3794-3802.2002 · Cited by 318
“Although bromodomains have now been found in more than 40 different proteins (13, 17, 39), the function of this motif is poorly understood.”
BackgroundLaurent, B. C., Treich, I., & Carlson, M. (1993) · Genes & Development · doi:10.1101/gad.7.4.583 · Cited by 305
A Bromodomain Protein, MCAP, Associates with Mitotic Chromosomes and Affects G2-to-M Transition
Dey, A., Ellenberg, J., Farina, A., Coleman, A. E., Maruyama, T., Sciortino, S., Lippincott-Schwartz, J., & Ozato, K. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.17.6537-6549.2000 · Cited by 301
Moosmann, P., Georgiev, O., Le Douarin, B., Bourquin, J.-P., & Schaffner, W. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.24.4859 · Cited by 286
Jeanmougin, F. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01042-6 · Cited by 279
Marcus, G. A., Silverman, N., Berger, S. L., Horiuchi, J., & Guarente, L. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06806.x · Cited by 276
Shang, E., Nickerson, H. D., Wen, D., Wang, X., & Wolgemuth, D. J. (2007) · Development · doi:10.1242/dev.004481 · Cited by 273
Chromatin and Transcription in Yeast
Rando, O. J., & Winston, F. (2012) · Genetics · doi:10.1534/genetics.111.132266 · Cited by 269
Self-citationXiao, H., Sandaltzopoulos, R., Wang, H.-M., Hamiche, A., Ranallo, R., Lee, K.-M., Fu, D., & Wu, C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00345-8 · Cited by 262
Chromatin dynamics: Interplay between remodeling enzymes and histone modifications
Swygert, S. G., & Peterson, C. L. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.02.013 · Cited by 256
Clinical trials for BET inhibitors run ahead of the science
Andrieu, G., Belkina, A. C., & Denis, G. V. (2016) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2016.06.004 · Cited by 247
Histones: At the Crossroads of Peptide and Protein Chemistry
Müller, M. M., & Muir, T. W. (2015) · Chemical Reviews · doi:10.1021/cr5003529 · Cited by 247
WSTF–ISWI chromatin remodeling complex targets heterochromatic replication foci
Bozhenok, L., Wade, P. A., & Varga‐Weisz, P. (2002) · The EMBO Journal · doi:10.1093/emboj/21.9.2231 · Cited by 236
The SAND domain structure defines a novel DNA-binding fold in transcriptional regulation
Bottomley (2001) · Nature Structural Biology · doi:10.1038/89675 · Cited by 224
Di Micco, R., Fontanals-Cirera, B., Low, V., Ntziachristos, P., Yuen, S. K., Lovell, C. D., Dolgalev, I., Yonekubo, Y., Zhang, G., Rusinova, E., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.055 · Cited by 217
Place your BETs: the therapeutic potential of bromodomains
Prinjha, R. K., Witherington, J., & Lee, K. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.12.002 · Cited by 197
Double bromodomain‐containing gene Brd2 is essential for embryonic development in mouse
Shang, E., Wang, X., Wen, D., Greenberg, D. A., & Wolgemuth, D. J. (2009) · Developmental Dynamics · doi:10.1002/dvdy.21911 · Cited by 156
“The bromodomain is an evolutionarily conserved 110 amino acid (aa) motif first identified by comparison of the Drosophila genes brahma and female sterile homeotic (fsh) and four other genes in yeast and humans (Haynes et al., 1992; Tamkun et al., 1992).”
BackgroundMasumi, A., Wang, I.-M., Lefebvre, B., Yang, X.-J., Nakatani, Y., & Ozato, K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1810 · Cited by 124
Targeting protein–protein interactions, a wide open field for drug design
Bakail, M., & Ochsenbein, F. (2016) · Comptes Rendus. Chimie · doi:10.1016/j.crci.2015.12.004 · Cited by 117
BET Bromodomain Proteins as Cancer Therapeutic Targets
Shu, S., & Polyak, K. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030908 · Cited by 72
Metadata
- Authors
- Haynes, S. R., Dollard, C., Winston, F., Beck, S., Trowsdale, J., & Dawid, I. B.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1992
- Volume
- 20
- Issue
- 10
- Pages
- 2603-2603
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W1992916802
- Cited by
- 387
- References
- 7
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.